Role of poly(ADP-ribose) synthetase in inflammation

European Journal of Pharmacology

Volumn 350, Issue 1, 1998, Pages 1-19

  Szabó, Csaba ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

3 Aminobenzamide; Diabetes; Endotoxin; Free radical; Inflammation; Mitochondrial respiration; Nicotinamide; Nitric oxide, (NO); Peroxynitrite; Poly(ADP ribose)synthetase; Septic shock; Stroke; Superoxide

Indexed keywords

ENDOTOXIN; FREE RADICAL; HYDROXYL RADICAL; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXYNITRITE; SUPEROXIDE; ZYMOSAN;

CELL DEATH; CELL LEVEL; CYTOTOXICITY; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; GENE EXPRESSION; INFLAMMATION; INFLAMMATORY DISEASE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ANIMALS; ENZYME ACTIVATION; FREE RADICALS; HUMANS; INFLAMMATION; POLY(ADP-RIBOSE) POLYMERASES; REPERFUSION INJURY;

EID: 0032577469     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00249-0     Document Type: Review

References (261)

1. Aiko S., Grisham M.B. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology. 109:1995;142-150.
2. Akaike T., Weihe E., Schaefer M.K.-H., Fu Z.F., Zheng Y.M., Vogel W.H., Schmidt H.H.H.W., Korpowski H., Dietzschold B. Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J. Neurovirol. 1:1995;118-125.
3. Albina J.E., Martin B.A., Henry W.L. Jr., Louis C.A., Reichner J.S. B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity. J. Immunol. 157:1996;279-283.
4. Allgayer H. Clinical relevance of oxygen radicals in inflammatory bowel disease - facts and fashion. Klin Wochenschr. 69:1991;1001-1003.
5. Althaus F.R., Hofferer L., Kleczkowska H.E., Malanga M., Naegeli H., Panzeter P.L., Realini C.A. Histone shuttling by poly-ADP-ribosylation. Mol. Cell. Biochem. 138:1994;53-59.
6. Aubel-Sadron G., Londos-Gagliardi D. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie. 66:1984;333-352.
7. Babbs C.F. Oxygen radicals in ulcerative colitis. Free Radic. Biol. Med. 13:1992;169-181.
8. Bagasra O., Michaels F.H., Zheng Y.M., Bobroski L.E., Spitsin S.V., Fu Z.F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;12041-12045.
9. Bauer P.I., Kirsten E., Varadi G., Young L.J., Hakam A., Comstock J.A., Kun E. Reversion of malignant phenotype by 5-iodo-6-amino-1,2-benzopyrone a non-covalently binding ligand of poly(ADP-ribose)polymerase. Biochimie. 77:1995;347-374.
10. Bauer P.I., Kirsten E., Young L.J.T., Varadi G., Csonka E., Buki K.G., Mikala G., Hu R., Comstock J.A., Mendeleyev J., Hakam A., Kun E. Modification of growth related enzymatic pathways and apparent loss of tumorigenicity of a ras-transformed bovine endothelial cell line by treatment with 5-iodo-6-amino-1,2-benzopyrone. Int. J. Oncol. 8:1996;239-252.
11. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271:1996;C1424-C1437.
12. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
13. Bellmann K., Wenz A., Radons J., Burkart V., Kleemann R., Kolb H. Heat shock induces resistance in rat pancreatic islet cells against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro. J. Clin. Invest. 95:1995;2840-2845.
14. Bellmann K., Jaattela M., Wissing D., Burkart V., Kolb H. Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett. 391:1996;185-188.
15. Bellosillo B., Dalmau M., Colomer D., Gil J.M. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood. 89:1997;3378-3384.
16. Berger N.A. Oxidant-induced cytotoxicity: a challenge for metabolic modulation. Am. J. Respir. Cell. Mol. Biol. 4:1991;1-3.
17. Berger S.J., Sudar D.C., Berger N.A. Metabolic consequences of DNA damage: DNA damage induces alterations in glucose metabolism by activation of poly(ADP-ribose)polymerase. Biochem. Biophys. Res. Commun. 134:1986;227-232.
18. Bolanos J.P., Almeida A., Stewart V., Peuchen S., Land J.M., Clark J.B., Heales S.J. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68:1997;2227-2240.
19. Bolton C., Paul C. MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J. Pharmacol. Exp. Ther. 282:1997;397-402.
20. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA. 92:1995;7162-7166.
21. Bonfoco E., Zhivotovsky B., Rossi A.D., Aguilar-Santelises M., Orrenius S., Lipton S.A., Nicotera P. Bcl-2 delay apoptosis and PARP cleavage induced by NO donors in GT1-7 cells. NeuroReport. 8:1996;273-627.
22. Boughton-Smith N.K., Evans S.M., Hawkey C.J., Cole A.T., Balsitis M., Whittle B.R.J., Moncada S. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet. 341:1993;338-340.
23. Brahn, E., Banquerigo, M.L., Firestein, G.S., Boyle, D.L., Salzman, A.L., Szabó, C., 1998. Collagen-induced arthritis: reversal by mercaptoethylguanidine, a novel anti-inflammatory agent with a combined mechanism of action. J. Rheumatol., in press.
24. Brenner T., Brocke S., Szafer F., Sobel R.A.M., Parkinsonm J.F., Perez D.H., Steinman L. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:1997;2940-2946.
25. Brett R., Rumsby M.G. Susceptibility of myelin glycerophospholipids and sphingolipids to oxidative attack by hydroxyl free radicals as measured by the thiobarbituric acid test. Neurochem. Int. 24:1994;241-251.
26. Bukrinsky M.I., Notter H.S.L.M., Schmidtmayerova H., Dubrovsky L., Flanagan C.R., Mullins M.E., Lipton S.A., Gendelman H.E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-accociated neurological disease. J. Exp. Med. 181:1995;735-745.
27. Chamulitrat W., Spitzer J.J. Generation of nitro and superoxide radical anions from 2,4,6-trinitrobenzenesulfonic acid by rat gastrointestinal cells. Biochim. Biophys. Acta. 1336:1997;73-82.
28. Cochrane C.G. Mechanisms of oxidant injury of cells. Mol. Aspects Med. 12:1991;137-147.
29. Cole G.A., Bauer G., Kirsten E., Mendeleyev J., Bauer P.I., Buki K.G., Hakam A., Kun E. Inhibition of HIV-1 IIIb replication in AA-2 and MT-2 cells in culture by two ligands of poly(ADP-ribose)polymerase: 6-amino-1,2-benzopyrone and 5-iodo-6-amino-1,2-benzopyrone. Biochem. Biophys. Res. Commun. 180:1991;504-514.
30. Collins A. Cellular responses to ionizing radiation: effects of interrupting DNA repair with chemical agents. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 51:1987;971-983.
31. Connor J., Manning P., Settle S., Moore W., Jerome G., Webber R., Tjoeng F., Currie M. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 273:1995;15-24.
32. Corbett J.A., Mikhael A., Shimizu J., Frederick K., Misko T.P., McDaniel M.L., Kanagawa O., Unanue E.R. Nitric oxide production in islet cells from nonobese mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA. 90:1993;8992-8995.
33. Cosi C., Colpaert F., Koek W., Degryse A., Marien M. Poly(ADP-ribose)polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res. 729:1996;264-269.
34. Costantini P., Chernyak B.V., Petronilli V., Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271:1996;6746-6751.
35. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
36. Cross A.H., Manning P.T., Stern M.K., Misko T.P. Evidence for the production of peroxynitrite inflammatory CNS demyelination. J. Neuroimmunol. 80:1997;121-130.
37. Cuzzocrea S., Zingarelli B., Costantino G., Szabó A., Salzman A.L., Caputi A.P., Szabó C. Beneficial effects of 3-aminobenzamide, an inhibitor of poly(ADP-ribose)synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br. J. Pharmacol. 121:1997;1065-1074.
38. Cuzzocrea S., Caputi A.P., Zingarelli B. Peroxynitrite-mediated DNA strand breakage activates poly(ADP-ribose)synthetase and causes cellular energy depletion in carrageenan-induced pleurisy. Immunology. 93:1998;96-101.
39. Cuzzocrea S., Zingarelli B., Gilad E., Hake P., Salzman A.L., Szabó C. Protective effects of 3-aminobenzamide, an inhibitor of poly(ADP-ribose)synthase in a carrageenan-induced model of local inflammation. Eur J. Pharmacol. 342:1998;67-76.
40. Dawson V.L., Dawson T.M. Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10:1996;179-190.
41. Dawson V.L., Dawson T.M., Uhl G.R., Snyder S.H. Human immunodeficiency virus type I coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 90:1993;3256-3259.
42. Deitch E.A., Bridges W., Berg R., Specian R.D., Granger D.N. Hemorrhagic shock-induced bacterial translocation: the role of neutrophils and hydroxyl radicals. J. Trauma. 30:1990;942-951.
43. Delaney C.A., Tyrberg B., Bouwens L., Vaghef H., Hellmann B., Eizirik D.L. Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett. 394:1996;300-306.
44. DeMurcia G., Huletsky A., Poirier G.G. Modulation of chromatin structure by polyADP-ribosylation. Biochem. Cell. Biol. 66:1988;626-635.
45. De Murcia J.M., Niedergang C., Trucco C., Ricoul M., Dutrillaux B., Mark M., Oliver F.J., Masson M., Dierich A., LeMeur M., Walztinger C., Chambon P., de Murcia G. Requirement of poly(ADP-ribose)polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7303-7307.
46. + content strictly depends on ATP concentration in isolated liver cells. FEBS Lett. 410:1997;329-332.
47. Dorheim M.A., Tracey W.R., Pollock J.S., Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem. Biophys. Res. Commun. 205:1994;659-665.
48. Ebadi M., Srinivasan S.K., Baxi M.D. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48:1996;1-19.
49. Ehrlich W., Huser H., Kroger H. Inhibition of the induction of collagenase by interleukin-1 β in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose)-polymerase inhibitor 3-aminobenzamide. Rheumatol. Int. 15:1995;171-172.
50. Eizirik D.L., Delaney C.A., Green M.H.L., Cunningham J.M., Thorpe J.R., Pipeleers D.G., Hellerstrom C., Green I.C. Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol. Cell. Endocrinol. 118:1996;71-83.
51. Eliasson M.J.L., Sampei K., Mandir A.S., Hurn P.D., Traystman R.J., Bao J., Pieper A., Wang Z.Q., Dawson T.M., Snyder S.H., Dawson V.L. Poly(ADP-ribose)polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med. 3:1997;1089-1095.
52. Elliott R.B., Pilcher C.C., Fergusson D.M., Stewart A.W. A population based strategy to prevent insulin-dependent diabetes using nicotinamide. J. Pediatr. Endocrinol. Metab. 9:1996;501-509.
53. Endres M., Wang Z.-Q., Namura S., Waeber C., Moskowitz M.A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cerebr. Blood. Flow. Metab. 17:1997;1143-1151.
54. Endres, M., Scott, G.S., Namura, S., Salzman, A.L., Moskowitz, M., Szabó, C., 1998. Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose)synthetase after cerebral ischemia-reperfusion. Neurosci. Lett., in press.
55. Eng L.F., Ghirnikar R.S., Lee Y.L. Inflammation in EAE: role of chemokine/cytokine expression by resident and infiltrating cells. Neurochem. Res. 21:1996;511-525.
56. Epe B., Ballmaier D., Roussyn I., Briviba K., Sies H. DNA damage by peroxynitrite characterized with DNA repair enzymes. Nucleic Acids Res. 24:1996;4105-4110.
57. Estevez A.G., Radi R., Barbeito L., Shin J.T., Thompson J.A., Beckman J.S. Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65:1995;1543-1550.
58. Evans C.H., Stefanovic-Racic M., Lancaster J. Nitric oxide and its role in orthopaedic disease. Clin. Orth. Rel. Res. 312:1995;275-294.
59. Fahn S., Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32:1992;804-812.
60. Farrell A.J., Blake D.R., Palmer R.M., Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51:1992;1219-1222.
61. Forman L.J., Liu P., Yin K., Wong P.Y.-K. Augmentation of nitric oxide, superoxide and peroxynitrite production during cerebral ischemia and reperfusion in the rat. Neurochem. Res. 23:1998;141-148.
62. French J.F., Thomas C.E., Downs T.R., Ohlweiler D.F., Carr A.A., Dage R.C. Protective effects of a cyclic nitrone antioxidant in animal models of endotoxic shock and chronic bacteremia. Circ. Shock. 43:1994;130-136.
63. Gale E.A. Theory and practice of nicotinamide trials in pre-type 1 diabetes. J. Pediatr. Endocrinol. Metab. 9:1996;375-379.
64. Galpern W.R., Matthews R.T., Beal M.F., Isacson O. NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease. Neuroreport. 7:1996;2639-2642.
65. Gijbels K., Galardy R.E., Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94:1994;2177-2182.
66. Gow A.J., Thom S.R., Ischiropoulos H. Nitric oxide and peroxynitrite-mediated pulmonary cell death. Am. J. Physiol. 274:1998;L112-L118.
67. Grabowski P.S., Macpherson H., Ralston S.H. Nitric oxide production in cells derived from the human joint. Br. J. Rheumatol. 35:1996;207-212.
68. Greenwald R.A. Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment. Semin. Arthritis Rheum. 20:1991;219-240.
69. Guenal I., Sidoti-de Fraisse C., Gaumer S., Mignotte B. Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogene. 15:1997;347-360.
70. Guy J., Ellis E.A., Hope G.M., Rao N.A. Antioxidant enzyme suppression of demyelination in experimental optic neuritis. Curr. Eye Res. 8:1989;467-477.
71. 2 and extravasated serum albumin. Invest. Ophthalmol. Vis. Sci. 35:1994;1114-1123.
72. Halliwell B., Aruoma O.I. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett. 281:1991;9-19.
73. Hardin-Pouzet H., Krakowski M., Bourbonniere L., Didier-Bazes M., Tran E. Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. GLIA. 20:1997;79-85.
74. Hauschildt S., Scheipers P., Bessler W.G., Mulsch A. Induction of nitric oxide synthase in L929 cells by tumour necrosis factor α is prevented by inhibitors of poly(ADP-ribose)polymerase. Biochem. J. 288:1992;255-260.
75. Hauselmann H.J., Opplinger L., Michel B.A., Stefanovic-Racic M., Evans C.H. Nitric oxide and proteoglycan synthesis by human articular chondrocytes in alginate culture. FEBS Lett. 352:1994;361-364.
76. Hayashi T., Abe E., Yamate T., Taguchi Y., Jasin H.E. Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum. 40:1997;261-269.
77. Heller B., Wang Z.Q., Wagner E.F., Radons J., Burkle A., Fehsel K., Burkart V., Kolb H. Inactivation of the poly(ADP-ribose)polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J. Biol. Chem. 270:1995;11176-11180.
78. Hiromatsu Y., Sato M., Yamada K., Nonaka K. Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-γ-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cells. Clin. Endocrinol. 36:1992;91-95.
79. Hirsch T., Marzo I., Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci. Rep. 17:1997;67-76.
80. Hogaboam C.M., Jacobson K., Collins S.M., Blennerhassett M.G. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am. J. Physiol. 31:1995;G673-G684.
81. Hooper D.C., Ohnishi T.S., Kean R., Numagami Y., Dietzschold B., Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA. 92:1995;5312-5316.
82. Hooper D.C., Bagasra O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., Champion J.M., Sarker A.B., Bobroski L., Farber J.L., Akaike T., Maeda H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 94:1997;2528-2533.
83. Hooper D.C., Spitsin S., Kean R.B., Champion J.M., Dickson G.M., Chaudhdy I., Koprowski H. Uric acid, a natural scavenger of peroxynitrite in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA. 95:1998;675-680.
84. Hough C.J., Smulson M.E. Association of poly(adenosine diphosphate ribosylated)nucleosomes with transcriptionally active and inactive regions of chromatin. Biochemistry. 23:1994;5016-5023.
85. Ialenti A., Moncada S., Di Rosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. Br. J. Pharmacol. 110:1993;701-706.
86. Ikeda I., Kasajima T., Ishiyama S., Shimojo T., Takeo Y., Nishikawa T., Kameoka S., Hiroe M., Mitsunaga A. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am. J. Gastroenterol. 92:1997;1339-1341.
87. Inada C., Yamada K., Takane N., Nonaka K. Poly(ADP-ribose)synthesis induced by nitric oxide in a mouse β-cell line. Life Sci. 56:1995;1467-1474.
88. Inoue S., Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett. 371:1995;86-88.
89. Ischiropoulos H., Zhu L., Beckman J.S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:1992;446-451.
90. Ischiropoulos H., Al-Mehdi A.B., Fisher A.B. Reactive species in ischemic rat lung injury: contribution of peroxynitrite. Am. J. Physiol. 269:1995;L158-L164.
91. Jenner P., Schapira A.H., Marsden C.D. New insights into the cause of Parkinson's disease. Neurology. 42:1992;2241-2250.
92. Junod A.F., Jornot L., Petersen H. Differential effects of hyperoxia and hydrogen peroxide on DNA damage, polyadenosine diphosphate-ribose polymerase activity, and nicotinamide adenine dinucleotide and adenosine triphosphate contents in cultured endothelial cells and fibroblasts. J. Cell Physiol. 140:1989;177-185.
93. Karlik S.J., Stavraky R.T., Hall E.D. Comparison of tirilazad mesylate (U-74006F) and methylprednisolone sodium succinate treatments in experimental allergic encephalomyelitis in the guinea pig. Multiple Sclerosis. 1:1996;228-235.
94. Kaufmann S.H., Desnoyers S., Ottaviano Y., Davidson N.E., Poirier G.G. Specific proteolytic cleavage of poly(ADP-ribose)polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:1993;3976-3985.
95. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350:1994;9-12.
96. Kaur H., Edmonds S.E., Blake D.R., Halliwell B. Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid. Ann. Rheum. Dis. 55:1996;915-920.
97. Keller J.N., Kindy M.S., Holtsberg F.W., Clair D.K., Yen H.C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction. J. Neurosci. 18:1998;687-697.
98. Kennedy M., Szabó C., Salzman A.L. Activation of polyADP ribosyl synthetase mediates cytotoxicity induced by peroxynitrite in human intestinal epithelial cells. Gastroenterology. 114:1998;510-518.
99. Kent S.J., Karlik S.J., Cannon C., Hines D.K., Yednock T.A., Fritz L.C., Horner H.C. A monoclonal antibody to α 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J. Neuroimmunol. 58:1995;1-10.
100. Keshavarzian A., Haydek J., Zabihi R., Doria M., D'Astice M., Sorenson J.R. Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis. Dig. Dis. Sci. 37:1992;1866-1873.
101. King P.A., Anderson V.E., Edwards J.O., Gustav G., Plumb R.C., Suggs J.W. A stable solid that generates hydroxyl radical dissolutions in aqueous solutions: reaction with proteins and nucleic acid. J. Am. Chem. Soc. 114:1992;5430-5432.
102. Kirkland J.B. Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells: role of activation of poly(ADP-ribose)polymerase. Biochim. Biophys. Acta. 1092:1991;319-325.
103. Kiss J., Lamarque D., Delchier J.C., Whittle B.J. Time-dependent actions of nitric oxide synthase inhibition on colonic inflammation induced by trinitrobenzene sulfonic acid in rats. Eur. J. Pharmacol. 336:1997;219-224.
104. Koka P., He K., Zack J.A., Kitchen S., Peacock W., Fried I., Tran T., Yashar S.S., Merrill J.E. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor α, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J. Exp. Med. 182:1995;941-952.
105. Kopin I.J., Markey S.P. MPTP toxicity: implications for research in Parkinson's disease. Annu. Rev. Neurosci. 11:1988;81-96.
106. Koprowski H., Zheng Y.M., Heber-Katz E., Fraser N., Rorke L., Fu Z.F., Hanlon C., Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA. 90:1993;3024-3027.
107. Kroger H., Miesel R., Dietrich A., Ohde M., Rajnavolgyi E., Ockenfels H. Synergistic effects of thalidomide and poly(ADP-ribose)polymerase inhibition on type II collagen-induced arthritis in mice. Inflammation. 20:1996;203-215.
108. Kröncke K.D., Fehsel K., Sommer A., Rodriguez M.L., Kolb-Bachofen V. Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotocin contributes to islet cell DNA damage. Biol. Chem. Hoppe-Seyler. 376:1995;179-185.
109. Kuo M.L., Chau Y.P., Wang J.H., Shiah S.G. Inhibitors of poly(ADP-ribose)polymerase block nitric oxide-induced apoptosis but not differentiation in human leukemia HL-60 cells. Biochem. Biophys. Res. Commun. 219:1996;502-508.
110. Kwon N.S., Lee S.H., Choi C.S., Kho T., Lee H.S. Nitric oxide generation from streptozotocin. FASEB J. 8:1994;529-533.
111. Lan J., Jiang D.H. Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J. Neural Transm. 104:1997;469-481.
112. Larsen K.H., Brash D., Cleaver J.E., Hart R.W., Maher V.M., Painter R.B., Sega G.A. DNA repair assays as tests for environmental mutagens. Mutat. Res. 98:1982;287-318.
113. Lautier D., Lagueux J., Thiboldeau J., Menard L., Poirier G.G. Molecular and biochemical features of poly(ADP-ribose)metabolism. Mol. Cell Biochem. 122:1993;171-193.
114. Laval F., Wink D.A. Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis. 15:1994;443-447.
115. Le Page C., Sanceau J., Drapier J.C., Wietzerbin J. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF κ B activation. Biochem. Biophys. Res. Commun. 243:1998;451-457.
116. Lee A.C., Xu X., Colombini M. The role of pyridine dinucleotides in regulating the permeability of the mitochondrial outer membrane. J. Biol. Chem. 271:1996;26724-26731.
117. Leist M., Single B., Kunstle G., Volbracht C., Hentze H., Nicotera P. Apoptosis in the absence of poly-(ADP-ribose)polymerase. Biochem. Biophys. Res. Commun. 233:1997;518-522.
118. Li X.J., Sharp A.H., Li S.H., Dawson T.M., Snyder S.H., Ross C.A. Huntington-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 93:1996;4839-4844.
119. Lin R.F., Lin T.-S., Tilton R.G., Cross A.H. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: An electron paramagnetic resonance study. J. Exp. Med. 178:1993;643-648.
120. Lin K.T., Xue J.Y., Nomen M., Spur B., Wong P.Y. Peroxynitrite-induced apoptosis in HL-60 cells. J. Biol. Chem. 270:1995;16487-16490.
121. Liu P., Hock C.E., Nagele R., Wong P.Y. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am. J. Physiol. 272:1997;H2327-H2336.
122. Lipton S.A., Yeh M., Dreyer E.B. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv. Neuroimmunol. 4:1994;181-188.
123. Lundberg J.O., Hellstrom P.M., Lundberg J.M., Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet. 344:1994;1673-1674.
124. Ma T.T., Ischiropoulos H., Brass C.A. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology. 108:1995;463-469.
125. Malfroy B., Doctrow S.R., Orr P.L., Tocco G., Fedoseyeva E.V., Benichou G. Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites. Cell Immunol. 177:1997;62-68.
126. Mannick J.B., Miao X.Q., Stamler J.S. Nitric oxide inhibits Fas-induced apoptosis. J. Biol. Chem. 272:1997;24125-24128.
127. Masiello P., Cubeddu T.L., Frosina G., Bergamini E. Protective effect of 3-aminobenzamide, an inhibitor of poly(ADP-ribose)synthetase, against streptozotocin-induced diabetes. Diabetologia. 28:1985;683-686.
128. Masiello P., Novelli M., Fierabbrachi V., Bergamini E. Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced β-cell toxicity in vivo and in vitro. Res. Commun. Chem. Pathol. Pharmacol. 69:1990;17-32.
129. Matheis G., Sherman M.P., Buckberg G.D., Haybron D.M., Young H.N., Ignarro L.J. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol. 262:1992;H616-H620.
130. McCartney-Francis N., Allen J.N., Mizel D.E., Albina J., Xie Q.W., Nathan C.F., Wahl S.M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:1993;749-753.
131. Meisterernst M., Stelzer G., Roeder R.G. Poly(ADP-ribose)polymerase enhances activator-dependent transcription in vitro. Proc. Natl. Acad. Sci. USA. 94:1997;2261-2265.
132. Melino G., Bernassola F., Knight R.A., Corasaniti M.T., Nistico G., Finazzi-Agro A. S-nitrosylation regulates apoptosis. Nature. 388:1997;432-433.
133. Messmer U.K., Brune B. Nitric oxide in apoptotic cersus necrotic RAW 264.7 macrophage cell death: the role of NO-donor exposure, NAD content and p53 accumulation. Arch. Biochem. Biophys. 327:1996;1-10.
134. Messmer U.K., Reimer D.M., Reed J.C., Brune B. Nitric oxide induced poly(ADP-ribose)polymerase cleavage in RAS 264.7 macrophage apoptosis is blocked by Bcl-2. FEBS Lett. 384:1996;162-166.
135. Middleton S.J., Shorthouse M., Hunter J.D. Increased nitric oxide synthesis in ulcerative colitis. Lancet. 341:1993;465-466.
136. Miesel R., Kurpisz M., Kroger H. Modulation of inflammatory arthritis by inhibition of poly(ADP-ribose)polymerase. Inflammation. 19:1995;379-387.
137. Miller M.J.S., Sadowska-Krowicka H., Chotinaruemol S., Kakkis J.L., Clark D.A. Amelioration of chronic ileitis by nitric oxide inhibition. J. Pharmacol. Exp. Ther. 264:1993;11-16.
138. Miller M.J.S., Thompson J.H., Zhang X.-J., Sadowska-Krowicka H., Kakkis J.L., Munshi U.K., Sandoval M., Rossi J.L., Eloby-Childress S., Beckman J.S., Ye Y.Z., Rodi P., Manning P.T., Currie M.G., Clark D.A. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology. 109:1995;1475-1483.
139. Mitrovic B., Ignarro L.J., Montestruque S., Smoll A., Merrill J.E. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience. 61:1994;575-585.
140. Miyagishi R., Kikuchi S., Takayama C., Inoue Y., Tashiro K. Identification of cell types producing RANTES, MIP-1 α and MIP-1 β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J. Neuroimmunol. 77:1997;17-26.
141. Mohr S., Zech B., Lapetina E.G., Brune B. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem. Biophys. Res. Commun. 238:1997;387-391.
142. Monti D., Cossarizza A., Salvioli S., Franceschi C., Rainaldi G., Straface E., Rivabene R., Malorni W. Cell death protection by 3-aminobenzamide and other poly(ADP-ribose)polymerase inhibitors: different effects on human natural killer and lymphokine activated killer cell activities. Biochem. Biophys. Res. Commun. 199:1994;525-530.
143. Monti D., Troiano L., Tropea F., Grassilli E., Cossarizza A., Barozzi D., Pelloni M.C., Tamassia M.G., Bellomo G., Francheschi C. Apoptosis-programmed cell death: a role in the aging process? Am. J. Clin. Nutr. 55:1995;1208S-1214S.
144. Mourelle M., Vilaseca J., Guarner F., Salas A., Malagelada J.R. Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am. J. Physiol. 33:1996;G425-G430.
145. Murrell G.A., Jang D., Williams R.J. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun. 206:1995;15-21.
146. Nagao M., Nakayasu M., Aonuma S., Shima H., Sugimura T. Loss of amplified genes by poly(ADP-ribose)polymerase inhibitors. Environ. Health Persp. 93:1991;169-174.
147. G-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J. Mol. Cell. Cardiol. 27:1995;419-426.
148. Nicholson D.W., Thornberry N.A. Caspases: killer proteases. Trends Biochem. Sci. 22:1997;299-306.
149. Nicholson D.W., All A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
150. O'Connor M., Salzman A.L., Szabó C. Role of peroxynitrite in the protein oxidation and apoptotic DNA fragmentation in immunostimulated vascular smooth muscle cells. Shock. 8:1997;439-443.
151. Ohta T., Kinoshita T., Naito M., Nozaki T., Masutani M., Tsuruo T., Miyajima A. Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells. J. Biol. Chem. 272:1997;23111-23116.
152. Osman J., Jablon S., Parrillo N.R., Easington C.R., Parrillo J.E., Hollenberg S.M. Poly-ADP ribosyl synthetase inhibition reverses vascular hyporeactivity in septic mice. Crit. Care Med. 26:1998;A134. (Suppl.).
153. Oyanagui Y. Nitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats. Life Sci. 54:1994;PL285-PL259.
154. Palomba L., Sestili P., Cattabeni F., Azzi A., Cantoni O. Prevention of necrosis and activation of apoptosis in oxidatively injured human myeloid leukemia U937 cells. FEBS Lett. 390:1996;91-94.
155. Parks D.A., Bulkley G.B., Granger D.N. Role of oxygen free radicals in shock, ischemia, and organ preservation. Surgery. 94:1983;428-432.
156. Paul C., Bolton C. Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int. J. Immunopharmacol. 17:1995;497-503.
157. Pellat-Seceunyk K., Wietzerbin J., Drapier J.C. Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages. Biochem. J. 297:1994;53-58.
158. Poderoso J.J., Carreras M.C., Lisdero C., Riobo N., Schopfer F., Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328:1996;85-92.
159. Pozzilli P., Visalli N., Cavallo M.G., Signore A., Baroni M.G., Buzzetti R., Fioriti E., Mesturino C., Fiori R., Romiti A., Giovannini C., Lucentini L., Matteoli M.C., Crino A., Teodonio C., Paci F., Amoretti R., Pisano L., Suraci M.T., Multari G., Suppa M., Sulli N., De Mattia G., Faldetta M.R., Ghirlanda G. Vitamin E and nicotinamide have similar effects in maintaining residual β cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study). Eur. J. Endocrinol. 137:1997;234-239.
160. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93:1996;4565-4571.
161. Qu Z., Fujimoto S., Taniguchi T. Enhancement of interferon-γ induced major histocompatibility complex class II gene expression by expressing an antisense RNA of poly(ADP-ribose)synthetase. J. Biol. Chem. 269:1994;5543-5547.
162. Rabinovitch A., Suarez-Pinzon W.L., Sorensen O., Bleackley R.C. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS expressing cells and relationships to cytokines expressed in the islet. Endocrinology. 137:1996;2093-2099.
163. Rachmilewitz D., Stamler J.S., Karmeli F., Mullins M.E., Singel D.J., Loscalzo J., Xavier R.J., Podolsky D.K. Peroxynitrite-induced rat colitis - A new model of colonic inflammation. Gastroenterology. 105:1993;1681-1688.
164. Rachmilewitz D., Karmeli F., Okon E. Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. Gastroenterology. 109:1995;98-106.
165. Radons J., Heller B., Burkle A., Hartmann B., Rodriguez M.L., Kroncke K.D., Burkart V., Kolb H. Nitric oxide toxicity in islet cells involves poly(ADP-ribose)polymerase activation and concomitant NAD depletion. Biochem. Biophys. Res. Commun. 199:1994;1270-1277.
166. Rees D.D. Role of nitric oxide in the vascular dysfunction of septic shock. Biochem. Soc. Transact. 23:1995;1025-1029.
167. Ribbons K.A., Zhang X.-J., Thompson J.H., Greenberg S.S., Moore W.M., Kornmeier C.M., Currie M.G., Lerche N., Blanchard J., Clark D.A., Miller M.J.S. Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology. 109:1995;1475-1483.
168. + homeostasis and respiration. Biosci. Rep. 17:1997;53-66.
169. 2 and tumor necrosis factor-α activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem. 270:1995;18974-18996.
170. Rosser B.G., Gores G.J. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology. 108:1995;252-275.
171. Rustin P., Parfait B., Chretien D., Bourgeron T., Djouadi F., Bastin J., Rotig A., Munnich A. Fluxes of nicotinamide adenine dinucleotides through mitochondrial membranes in human cultured cells. J. Biol. Chem. 271:1996;14785-14790.
172. Ruuls S.R., Bauer J., Sontrop K., Huitinga I., Hart B.A., Dijkstra C.D. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 56:1995;207-217.
173. Sakurai H., Kohsaka H., Liu M.F., Higashiyama H., Hirata Y., Kanno K., Saito I., Miyasaka N. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96:1995;2357-2363.
174. Salgo M.G., Bermudez E., Squadrito G., Pryor W. DNA damage and oxidation of thiols peroxynitrite causes in rat thymocytes. Arch. Biochem. Biophys. 322:1995;500-505.
175. Salgo M.G., Squadrito G.L., Pryor W.A. Peroxynitrite causes apoptosis in rat thymocytes. Biochem. Biophys. Res. Commun. 215:1995;1111-1118.
176. Salgo M.G., Stone K., Squadrito G.L., Battista J.R., Pryor W.A. Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem. Biophys. Res. Commun. 210:1995;1025-1030.
177. Salzman, A.L., Zingarelli, B., Cuzzocrea, S., Szabó, C., 1997. Role of peroxynitrite and poly(ADP-ribose)synthetase activation in experimental colitis. Jpn. J. Pharmacol. 75 (Suppl., 15P).
178. Santos L., Tipping P.G. Attenuation of adjuvant arthritis in rats by treatment with oxygen radical scavengers. Immunol. Cell. Biol. 72:1994;406-414.
179. Sastry S.S., Buki K., Kun E. Binding of adenosine diphosphoribosyltransferase to the termini and internal regions of linear DNA. Biochemistry. 28:1989;5680-5687.
180. Schraufstatter I., Hinshaw D., Hyslop P., Spragg R., Cochrane C. Oxidant injury of cells. DNA strand breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J. Clin. Invest. 77:1986;1312-1330.
181. Schraufstatter I.U., Hyslop P.A., Jackson J.H., Cochrane C.G. Oxidant-induced DNA damage of target cells. J. Clin. Invest. 82:1988;1040-1050.
182. Schulz R., Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc. Res. 30:1995;432-439.
183. Schulz J.B., Matthews R.T., Muqit M.M., Browne S.E., Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64:1995;936-939.
184. Schulz J.B., Matthews R.T., Klockgether T., Dichgans J., Beal M.F. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol. Cell. Biochem. 174:1997;193-197.
185. Scott, G.S., Hake, P., Salzman, A.L., Szabó, C., 1988. Suppression of experimental allergic encephalomyelitis by administration of 5-iodo-6-amino-1,2,benzopyrone, a novel inhibitor of poly(ADP-ribose)synthetase. Crit. Care Med. 26 (Suppl., A36).
186. Shoji Y., Uedono Y., Ishikura H., Takeyama N., Tanaka T. DNA damage induced by tumour necrosis factor-α in L929 cells is mediated by mitochondrial oxygen radical formation. Immunology. 84:1995;543-548.
187. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 111:1996;871-885.
188. Smith T.S., Bennett J.P. Jr. Mitochondrial toxins in models of neurodegenerative diseases: I. In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions. Brain Res. 765:1997;183-188.
189. Smulson M.E., Kang V.H., Ntambi J.M., Rosenthal D.S., Ding R., Simbulan C.M. Requirement for the expression of poly(ADP-ribose)polymerase during the early stages of differentiation of 3T3-L1 preadipocytes, as studied by antisense RNA induction. J. Biol. Chem. 270:1995;119-127.
190. Snyder S.H. No NO prevents parkinsonism. Nature Med. 2:1996;65-66.
191. Southan G.J., Szabó C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51:1996;383-394.
192. Spragg R.G. DNA strand break formation following exposure of bovine pulmonary artery and aortic endothelial cells to reactive oxygen products. Am. J. Respir. Cell. Mol. Biol. 4:1991;4-10.
193. Stefanovic-Racic M., Stadler J., Evans C.H. Nitric oxide and arthritis. Arthritis Rheum. 36:1993;1036-1044.
194. Stefanovic-Racic M., Meyers K., Meschter C., Coffey J.W., Hoffman R.A., Evans C.H. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum. 37:1994;1062-1069.
195. Stefanovic-Racic M., Meyers K., Meschter C., Coffey J.W., Hoffman R.A., Evans C.H. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J. Rheumatol. 22:1995;1922-1928.
196. Stichtenoth D.O., Fauler J., Zeidler H., Frolich J.C. Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann. Rheum. Dis. 54:1995;820-824.
197. Suarez-Pinzon W.L., Strynadka K., Schulz R., Rabinovitch A. Mechanism of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology. 134:1994;1006-1010.
198. Suarez-Pinzon W.L., Szabó C., Rabinovitch A. Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet β-cells. Diabetes. 46:1997;907-911.
199. Szabó C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons. 3:1995;2-32.
200. Szabó C. DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic. Biol. Med. 21:1996;855-869.
201. Szabó C. The role of peroxynitrite in the pathophysiology of shock, inflammation and ischemia-reperfusion injury. Shock. 6:1996;79-88.
202. Szabó C. Potential role of the peroxynitrite-poly(ADP-ribose)synthetase pathway in a rat model of severe hemorrhagic shock. Shock. 9:1998;341-344.
203. Szabó C., Salzman A.L. Endogenous peroxynitrite is involved in the inhibition of cellular respiration in immuno-stimulated J774.2 macrophages. Biochem. Biophys. Res. Commun. 209:1995;739-743.
204. Szabó C., Thiemermann C. Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock. 2:1994;145-155.
205. Szabó C., Salzman A.L., Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of NO synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett. 363:1995;235-238.
206. Szabó C., Salzman A.L., Ischiropoulos H. Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett. 372:1995;229-232.
207. Szabó C., Zingarelli B., Salzman A.L. Role of poly-ADP ribosyltransferase activation in the nitric oxide- and peroxynitrite-induced vascular failure. Circ Res. 78:1996;1051-1063.
208. Szabó C., Zingarelli B., O'Connor M., Salzman A.L. DNA strand breakage, activation of poly-ADP ribosyl synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. USA. 93:1996;1753-1758.
209. Szabó C., Wong H.R., Salzman A.L. Heat shock phenotype inhibits peroxynitrite-induced activation of poly(ADP)ribosyl synthetase and protects against peroxynitrite cytotoxicity in J774 macrophages. Eur. J. Pharmacol. 315:1996;221-226.
210. Szabó C., Day B.J., Salzman A.L. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages, using a novel mesoporphyrin superoxide dismutase analog and peroxynitrite scavenger. FEBS Lett. 381:1996;82-86.
211. Szabó C., Cuzzocrea S., Zingarelli B., O'Connor M., Salzman A.L. Endothelial dysfunction in endotoxic shock: importance of the activation of poly(ADP-ribose)synthetase (PARS) by peroxynitrite. J. Clin. Invest. 100:1997;723-735.
212. Szabó C., Lim L.H., Cuzzocrea S., Getting S.J., Zingarelli B., Flower R.J., Salzman A.L., Perretti M. Inhibition of poly(ADP-ribose)synthetase exerts anti-inflammatory effects and inhibits neutrophil recruitment. J. Exp. Med. 186:1997;1041-1049.
213. Szabó C., Saunders C., O'Connor M., Salzman A.L. Peroxynitrite causes energy depletion and increases permeability via activation of poly-ADP ribosyl synthetase in pulmonary epithelial cells. Am. J. Mol. Cell. Respir. Biol. 16:1997;105-109.
214. Szabó C., Wong H.R., Bauer P.I., Kirsten E., O'Connor M., Zingarelli B., Mendeleyev J., Hasko G., Vizi E.S., Salzman A.L., Kun E. Regulation of components of the inflammatory response by 5-iodo-6-amino-1,2-benzopyrone, and inhibitor of poly(ADP-ribose)synthetase and pleiotropic modifier of cellular signal pathways. Int. J. Oncol. 10:1997;1093-1101.
215. Szabó, A., Salzman, A.L., Szabó, C., 1998a. Poly(ADP-ribose)synthetase mediates neutrophil sequestration and lipid peroxidation after mesenteric ischemia. Shock, in press.
216. Szabó C., Virág L., Cuzzocrea S., Scott G.J., Hake P., O'Connor M.P., Zingarelli B., Salzman A.L., Kun E. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose)synthetase. Proc. Natl. Acad. Sci. USA. 95:1998;3867-3872.
217. Takahashi K., Greenberg J.H., Jackson P., Maclin K., Zhang J. Neuroprotective effects of inhibiting poly(ADP-ribose)synthetase on focal cerebral ischemia in rats. J. Cerebr. Blood Flow Metab. 17:1997;1137-1142.
218. Takeyama N., Matsuo N., Tanaka T. Oxidative damage to mitochondria is mediated by the calcium-dependent inner-membrane permeability transition. Biochem. J. 294:1993;719-725.
219. Tamir S., Burney S., Tannenbaum S.R. DNA damage by nitric oxide. Chem. Res. Toxicol. 9:1996;821-827.
220. Taniguchi T., Nemoto Y., Ota K., Imai T., Tobari J. Participation of poly(ADP-ribose)synthetase in the process of norepinephrine-induced inhibition of major histocompatibility complex class II antigen expression in human astrocytoma cells. Biochem. Biophys. Res. Commun. 193:1993;886-889.
221. Thiemermann C., Bowes J., Myint F.P., Vane J.R. Inhibition of the activity of poly(ADP-ribose)synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. USA. 94:1997;679-683.
222. Thies R.L., Autor A.P. Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by polyADP-ribose polymerase activation causing NAD depletion and altered energy balance. Arch. Biochem. Biophys. 286:1991;353-363.
223. Tsujimoto Y., Shimizu S., Eguchi Y., Kamiike W., Matsuda H. Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways. Leukemia. Suppl. 3:1997;380-382.
224. Turk J., Corbett J.A., Ramanadham S., Bohrer A., McDaniel M.L. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 197:1993;1458-1464.
225. Tzeng E., Kim Y.M., Pitt B.R., Lizonova A., Kovesdi I., Billiar T.R. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery. 122:1997;255-263.
226. Uchigata Y., Yamamoto H., Kawamura A., Okamoto H. Protection by superoxide dismutase, catalase, and poly(ADP-ribose)synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J. Biol. Chem. 257:1982;6084-6088.
227. Uchigata Y., Yamamoto H., Nagai H., Okamoto H. Effect of poly(ADP-ribose)synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes. 32:1983;316-318.
228. Ueta K., Hayashi O. ADP-ribosylation. Ann. Rev. Biochem. 54:1985;73-100.
229. Van der Laan L.J., Ruuls S.R., Weber K.S., Lodder I.J., Dopp E.A., Dijkstra C.D. Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-α and NO. J. Neuroimmunol. 70:1996;145-152.
230. Van der Veen R.C., Hinton D.R., Incardonna F., Hofman F.M. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77:1997;1-7.
231. Villa L.M., Salas E., Darley-Usmar M., Radomski M.E.W., Moncada S. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc. Natl. Acad. Sci. USA. 91:1994;12383-12387.
232. Virág L., Scott G.S., Salzman A.L., Szabó C. Effect of inhibition of poly(ADP-ribose)synthetase on peroxynitrite-induced thymocyte apoptosis. Crit. Care Med. 26:1998;A73. (Suppl.).
233. Virág, L., Scott, G.S., Marmer, D., Salzman, A.L., Szabó, C., 1998b. Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly-(ADP-ribose)synthetase (PARS) activation. Immunology, in press.
234. Virág, L., Salzman, A.L., Szabó, C., 1998c. Mechanisms of peroxynitrite-induced necrosis and apoptosis. Naunyn-Schmiedeberg's Arch. Pharmacol. (Suppl.), in press.
235. Wachsman J.T. The beneficial effects of dietary restriction: reduced oxidative damage and enhanced apoptosis. Mutat. Res. 350:1996;25-34.
236. Wallstrom E., Diener P., Ljungdahl A., Khademi M., Nilsson C.G., Olsson T. Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis. J. Neurol. Sci. 137:1996;89-96.
237. Wang P., Zweier J.L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. J. Biol. Chem. 271:1996;29223-29230.
238. Wang Z.Q., Auer B., Stingl L., Berghammer H., Haidacher D., Schweiger M., Wagner E.F. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9:1995;510-520.
239. Wang Z.-Q., Stingl L., Morrison C., Jantsch M., Los M., Schulze-Osthoff K., Wagner E.F. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. 11:1997;2347-2358.
240. 2 but not apoptosis. Gastroenterology. 109:1995;472-482.
241. G-monomethyl-L-arginine. J. Exp. Med. 179:1994;651-660.
242. White C.R., Brock T.A., Chang L.Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA. 91:1994;1044-1048.
243. White C.R., Darley-Usmar V., Berrington W.R., McAdams M., Gore J.Z., Thompson J.A., Parks D.A., Tarpey M.M., Freeman B.A. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc. Natl. Acad. Sci. USA. 93:1996;8745-8749.
244. Wink D.A., Laval J. The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis. 15:1994;2125-2129.
245. Wizemann T., Gardner C., Laskin J., Quinones S., Durham S., Goller N., Ohnishi T., Laskin D. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J. Leukocyte Biol. 56:1994;759-768.
246. Yamada T., Sartor R.B., Marshall S., Specian R.D., Grisham M.B. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology. 106:1993;759-771.
247. Yamamoto H., Uchigata Y., Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose)synthetase in pancreatic islets. Nature. 294:1981;284-286.
248. Yamamoto K., Tsukidate K., Farber J.L. Differing effects of the inhibition of polyADP-ribose polymerase on the course of oxidative cell injury in hepatocytes and fibroblasts. Biochem. Pharmacol. 46:1993;483-491.
249. Yoon Y.S., Kim J.W., Kang K.W., Kim Y.S., Choi K.H., Joe C.O. Poly(ADP-ribosyl)ation of histone H1 correlates with internucleosomal DNA fragmentation during apoptosis. J. Biol. Chem. 271:1996;9129-9134.
250. Youdim M.B., Lavie L., Riederer P. Oxygen free radicals and neurodegeneration in Parkinson's disease: a role for nitric oxide. Ann. N.Y. Acad. Sci. 738:1994;64-68.
251. Yu L., Gengaro P.E., Niederberger M., Burke T.J., Schrier R.W. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc. Natl. Acad. Sci. USA. 91:1994;1691-1695.
252. Zamzami N., Hirsch T., Dallaporta B., Petit P.X., Kroemer G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomembr. 29:1997;185-193.
253. Zhang J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide activation of poly(ADP-ribose)synthetase in neurotoxicity. Science. 263:1994;687-689.
254. Zhang J., Pieper A., Snyder S.H. Poly(ADP-ribose)synthetase activation: an early indicator of neurotoxic DNA damage. J. Neurochem. 65:1995;1411-1414.
255. Zingarelli B., O'Connor M., Wong H., Salzman A.L., Szabó C. Peroxynitrite-mediated DNA strand breakage activates poly-ADP ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol. 156:1996;350-358.
256. Zingarelli B., Salzman A.L., Szabó C. Protective effects of nicotinamide against nitric oxide-mediated vascular failure in endotoxic shock: potential involvement of polyADP ribosyl synthetase. Shock. 4:1996;258-264.
257. Zingarelli B., Day B.J., Crapo J., Salzman A.L., Szabó C. The potential involvement of peroxynitrite in the pathogenesis of endotoxic shock. Br. J. Pharmacol. 120:1997;259-267.
258. Zingarelli B., Ischiropoulos H., Salzman A.L., Szabó C. Improved vascular contractility and cellular energetics in the delayed phase of hemorrhagic shock by mercaptoethylguanidine, a novel inhibitor of the inducible isoform of nitric oxide synthase. Eur. J. Pharmacol. 338:1997;55-65.
259. Zingarelli B., Cuzzocrea S., Zsengeller Z., Salzman A.L., Szabó C. Beneficial effect of inhibition of poly-ADP-ribose synthetase activity in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 36:1997;205-215.
260. Zingarelli B., Salzman A.L., Szabó C. Poly(ADP-ribose)synthetase modulates expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia-reperfusion injury. FASEB J. 12:1998;A775.
261. Zizi M., Forte M., Blachly-Dyson E., Colombini M. NADH regulates the gating of VDAC, the mitochondrial outer membrane channel. J. Biol. Chem. 269:1994;1614-1616.